Effects of daily versus weekly teriparatide for medication‐related osteonecrosis of the jaw: A case–control study
出版年份 2023 全文链接
标题
Effects of daily versus weekly teriparatide for medication‐related osteonecrosis of the jaw: A case–control study
作者
关键词
-
出版物
ORAL DISEASES
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-06
DOI
10.1111/odi.14801
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaw – 2022 Update
- (2022) Salvatore L. Ruggiero et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases
- (2021) Peter Burckhardt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05
- (2021) H. Hagino et al. OSTEOPOROSIS INTERNATIONAL
- Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series
- (2021) Daigo Yoshiga et al. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
- Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
- (2021) Jin-Woo Kim et al. Journal of Bone Metabolism
- Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial
- (2020) Ie-Wen Sim et al. JOURNAL OF CLINICAL ONCOLOGY
- The role, efficacy and outcome measures for teriparatide use in the management of medication-related osteonecrosis of the jaw
- (2020) M. Anabtawi et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study
- (2017) Junho Jung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?
- (2017) Jung-Hyun Park et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Frequency of Teriparatide Administration Affects the Histological Pattern of Bone Formation in Young Adult Male Mice
- (2016) Tomomaya Yamamoto et al. ENDOCRINOLOGY
- Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings
- (2015) H. Kakehashi et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- PTH Promotes Bone Anabolism by Stimulating Aerobic Glycolysis via IGF Signaling
- (2015) Emel Esen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
- (2012) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Parathyroid Hormone Applications in the Craniofacial Skeleton
- (2012) H.L. Chan et al. JOURNAL OF DENTAL RESEARCH
- Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
- (2011) F. Saad et al. ANNALS OF ONCOLOGY
- Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis
- (2011) W. C. Dougall CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started